Darktrace Company Description

Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Canada, Europe, and internationally.

Its products include Enterprise Immune System to discover unpredictable cyber-threats; Industrial Immune System to detect novel threats and vulnerabilities, as well as safeguard the integrity and resilience of industrial technologies; and Cyber AI Analyst, an AI investigation technology, which automatically triages, interprets, and reports scope of security incidents.

The company also provides Darktrace Antigena, an autonomous response technology for the enterprise with various security products that delivers proactive cyber defense to digital infrastructure.

It serves critical national infrastructure organizations, financial services companies, technology and healthcare providers, media corporations, and educational institutions.

The company was founded in 2013 and is headquartered in Cambridge, the United Kingdom.

Darktrace plc

Country	United Kingdom
Founded	2013
Industry	Software - Infrastructure
Sector	Technology
Employees	2,200
CEO	Jill Popelka

Contact Details

Address: Maurice Wilkes Building Cambridge
Phone	44 1223 394 100

Stock Details

Ticker Symbol	DARK
Exchange	London Stock Exchange
Fiscal Year	July - June
Reporting Currency	USD
ISIN Number	GB00BNYK8G86
SIC Code	7370

Key Executives

Name	Position
Jill Popelka	Chief Executive Officer, Chief Operating Officer and Director
Catherine A. Graham	Chief Financial Officer and Executive Director
Poppy Clare Veronica Gustafsson O.B.E.	Executive Director
Jack Stockdale O.B.E.	Co-Founder and Chief Technology Officer
Luk Janssens	Head of Investor Relations
James Alan Sporle	General Counsel and Company Secretary
John Allen	Vice President of Cyber Risk and Compliance
Chris Kozup	Chief Marketing Officer
David Smith	Chief People Officer
Nicole Eagan	Chief Strategy Officer and AI Officer